Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China

• Published in: Annals of intensive care Vol. 10; no. 1; pp. 73 - 24
• Main Authors: Shang, You, Pan, Chun, Yang, Xianghong, Zhong, Ming, Shang, Xiuling, Wu, Zhixiong, Yu, Zhui, Zhang, Wei, Zhong, Qiang, Zheng, Xia, Sang, Ling, Jiang, Li, Zhang, Jiancheng, Xiong, Wei, Liu, Jiao, Chen, Dechang
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 06-06-2020; Springer Nature B.V; SpringerOpen
• Subjects: Anesthesiology; Coronaviruses; COVID-19; Critical care; Critical Care Medicine; Emergency Medicine; Expert statement; Experts; Intensive; Intensive care; Medicine; Medicine & Public Health; Review; China; COVID-19; Critical care; Expert statement
• ISSN: 2110-5820; 2110-5820
• DOI: 10.1186/s13613-020-00689-1

Background
The ongoing coronavirus disease 2019 (COVID-2019) pandemic has swept all over the world, posing a great pressure on critical care resources due to large number of patients needing critical care. Statements from front-line experts in the field of intensive care are urgently needed.
Methods
Sixteen front-line experts in China fighting against the COVID-19 epidemic in Wuhan were organized to develop an expert statement after 5 rounds of expert seminars and discussions to provide trustworthy recommendation on the management of critically ill COVID-19 patients. Each expert was assigned tasks within their field of expertise to provide draft statements and rationale. Parts of the expert statement are based on epidemiological and clinical evidence, without available scientific evidences.
Results
A comprehensive document with 46 statements are presented, including protection of medical personnel, etiological treatment, diagnosis and treatment of tissue and organ functional impairment, psychological interventions, immunity therapy, nutritional support, and transportation of critically ill COVID-19 patients. Among them, 5 recommendations were strong (Grade 1), 21 were weak (Grade 2), and 20 were experts’ opinions. A strong agreement from voting participants was obtained for all recommendations.
Conclusion
There are still no targeted therapies for COVID-19 patients. Dynamic monitoring and supportive treatment for the restoration of tissue vascularization and organ function are particularly important.